Company
Headquarters: Krakow, Poland
Employees: 542
€235.8 Million
EUR as of July 1, 2024
US$253.3 Million
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $204.45 B |
| Danaher | $177.21 B |
| Siemens Healthineers AG | $63.84 B |
| DexCom, Inc. | $45.21 B |
| Lonza Group Ltd | $39.85 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Voxel S.A. operates a network of diagnostic imaging laboratories. Its diagnostic imaging services include magnetic resonance imaging scans, computed tomography scans, positron emission tomography, and single photon emission computed tomography. The company also provides services in the field of diagnostic imaging, teleradiology, and outsourcing; and information systems for hospitals and diagnostic centers. In addition, it deals with the implementation of projects related to the outfitting of diagnostic laboratories. The company operates through a network of 33 specialized laboratories in 21 cities in Poland. Voxel S.A. was founded in 2005 and is based in Kraków, Poland.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Voxel SA has the following listings and related stock indices.
Stock: FSX: 0NX wb_incandescent